161 related articles for article (PubMed ID: 19803526)
1. Gold(I) analogues of a platinum-acridine antitumor agent are only moderately cytotoxic but show potent activity against Mycobacterium tuberculosis.
Eiter LC; Hall NW; Day CS; Saluta G; Kucera GL; Bierbach U
J Med Chem; 2009 Nov; 52(21):6519-22. PubMed ID: 19803526
[TBL] [Abstract][Full Text] [Related]
2. PT-ACRAMTU, a platinum-acridine anticancer agent, lengthens and aggregates, but does not stiffen or soften DNA.
Dutta S; Snyder MJ; Rosile D; Binz KL; Roll EH; Suryadi J; Bierbach U; Guthold M
Cell Biochem Biophys; 2013; 67(3):1103-13. PubMed ID: 23636685
[TBL] [Abstract][Full Text] [Related]
3. Effect of the diamine nonleaving group in platinum-acridinylthiourea conjugates on DNA damage and cytotoxicity.
Guddneppanavar R; Choudhury JR; Kheradi AR; Steen BD; Saluta G; Kucera GL; Day CS; Bierbach U
J Med Chem; 2007 May; 50(9):2259-63. PubMed ID: 17408248
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems?
Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF
J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390
[TBL] [Abstract][Full Text] [Related]
5. A non-cross-linking platinum-acridine agent with potent activity in non-small-cell lung cancer.
Ma Z; Choudhury JR; Wright MW; Day CS; Saluta G; Kucera GL; Bierbach U
J Med Chem; 2008 Dec; 51(23):7574-80. PubMed ID: 19012390
[TBL] [Abstract][Full Text] [Related]
6. New heteronuclear gold(I)-platinum(II) complexes with cytotoxic properties: are two metals better than one?
Wenzel M; Bigaeva E; Richard P; Le Gendre P; Picquet M; Casini A; Bodio E
J Inorg Biochem; 2014 Dec; 141():10-16. PubMed ID: 25172993
[TBL] [Abstract][Full Text] [Related]
7. 6-Mercaptopurine complexes with silver and gold ions: anti-tuberculosis and anti-cancer activities.
Cuin A; Massabni AC; Pereira GA; Leite CQ; Pavan FR; Sesti-Costa R; Heinrich TA; Costa-Neto CM
Biomed Pharmacother; 2011 Aug; 65(5):334-8. PubMed ID: 21775091
[TBL] [Abstract][Full Text] [Related]
8. Thermally inert metal ammines as light-inducible DNA-targeted agents. Synthesis, photochemistry, and photobiology of a prototypical rhodium(III)-intercalator conjugate.
Barry CG; Turney EC; Day CS; Saluta G; Kucera GL; Bierbach U
Inorg Chem; 2002 Dec; 41(26):7159-69. PubMed ID: 12495358
[TBL] [Abstract][Full Text] [Related]
9. Effect of linkage geometry on biological activity in thiourea- and guanidine-substituted acridines and platinum-acridines.
Ma Z; Saluta G; Kucera GL; Bierbach U
Bioorg Med Chem Lett; 2008 Jul; 18(13):3799-801. PubMed ID: 18515101
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological activity of a novel non-cisplatin-type platinum-acridine pharmacophore.
Martins ET; Baruah H; Kramarczyk J; Saluta G; Day CS; Kucera GL; Bierbach U
J Med Chem; 2001 Dec; 44(25):4492-6. PubMed ID: 11728195
[TBL] [Abstract][Full Text] [Related]
11. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
[TBL] [Abstract][Full Text] [Related]
12. New bio-sensitive and biologically active single crystal of pyrimidine scaffold ligand and its gold and platinum complexes: DFT, antimicrobial, antioxidant, DNA interaction, molecular docking with DNA/BSA and anticancer studies.
Sankarganesh M; Dhaveethu Raja J; Sakthikumar K; Solomon RV; Rajesh J; Athimoolam S; Vijayakumar V
Bioorg Chem; 2018 Dec; 81():144-156. PubMed ID: 30121002
[TBL] [Abstract][Full Text] [Related]
13. Copper(I) and silver(I) complexes of anthraldehyde thiosemicarbazone: synthesis, structure elucidation,
Khan A; Paul K; Singh I; Jasinski JP; Smolenski VA; Hotchkiss EP; Kelley PT; Shalit ZA; Kaur M; Banerjee S; Roy P; Sharma R
Dalton Trans; 2020 Dec; 49(47):17350-17367. PubMed ID: 33210698
[TBL] [Abstract][Full Text] [Related]
14. A review on acridinylthioureas and its derivatives: biological and cytotoxic activity.
Kožurková M; Sabolová D; Kristian P
J Appl Toxicol; 2017 Oct; 37(10):1132-1139. PubMed ID: 28370171
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a Chiral DNA-Targeted Platinum-Acridine Agent with Potent Enantioselective Anticancer Activity.
Zhang S; Yao X; Watkins NH; Rose PK; Caruso SR; Day CS; Bierbach U
Angew Chem Int Ed Engl; 2020 Dec; 59(49):21965-21970. PubMed ID: 32835419
[TBL] [Abstract][Full Text] [Related]
16. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
Sriram D; Yogeeswari P; Dinakaran M; Thirumurugan R
J Antimicrob Chemother; 2007 Jun; 59(6):1194-6. PubMed ID: 17449482
[TBL] [Abstract][Full Text] [Related]
17. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
Liu W; Bensdorf K; Proetto M; Abram U; Hagenbach A; Gust R
J Med Chem; 2011 Dec; 54(24):8605-15. PubMed ID: 22091836
[TBL] [Abstract][Full Text] [Related]
18. Acridine-decorated cyclometallated gold(iii) complexes: synthesis and anti-tumour investigations.
Williams MRM; Bertrand B; Fernandez-Cestau J; Waller ZAE; O'Connell MA; Searcey M; Bochmann M
Dalton Trans; 2018 Oct; 47(38):13523-13534. PubMed ID: 30204186
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents.
Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J
J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 4-aminoquinoline analogues and their platinum(II) complexes as new antileishmanial and antitubercular agents.
Carmo AM; Silva FM; Machado PA; Fontes AP; Pavan FR; Leite CQ; Leite SR; Coimbra ES; Da Silva AD
Biomed Pharmacother; 2011 Jun; 65(3):204-9. PubMed ID: 21602021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
